This paper records a patient of Osler’s, who showed many features compatible with the Churg-Strauss syndrome of allergic granulomatous angiitis to be described 50 years later.

Keywords:
Churg-Strauss syndrome, Allergic granulomatous angiitis, Vasculitis, Osler
1.
Chumbley LC, Harrison EG, DeRemee RA: Allergic granulomatosis and angiitis (Churg-Strauss syndrome). Mayo Clin Proc 1977;52:477–484.
2.
Lanham JG, Elkon KB, Pusey CD, et al: Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore) 1984;63:65–81.
3.
Osler W: Case of asthma with cyanosis, extensive purpura, painful muscles, and eosinophilia. Bull Johns Hopkins Hosp 1901;12:17.
4.
Warren P: Osler’s unusual case – was it Churg-Strauss syndrome? Can Med Assoc J 1999;161:846–847.
5.
Churg J, Strauss L: Allergic granulomatosis, allergic angiitis and periarteritis nodosa. Am J Pathol 1951;27:277–294.
6.
Lanham JG, Churg J: Churg-Strauss syndrome; in Churg A, Churg J (eds): Systemic Vasculitides. New York, Igaku-Shoin, 1991, pp 101–120.
7.
Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, et al: The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990;33:1094–1100.
8.
Abril A, Calamia KT, Cohen MD: The Churg-Strauss syndrome (allergic granulomatous angiitis): review and update. Semin Arthritis Rheum 2003;33:106–114.
9.
Sehgal M, Swanson JW, DeRemee RA, Colby TV: Neurologic manifestations of Churg-Strauss syndrome. Mayo Clin Proc 1995;70:337–341.
10.
Noth I, Strek ME, Leff AR: Churg-Strauss syndrome. Lancet 2003;361:587–594.
11.
Scolding NJ, Joseph F, Kirby PA, Mazanti I, et al: Abeta-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy. Brain 2005;128:500–515.
12.
Streho M, Sable-Fourtassou R, Charlotte Brion M, Bourotte I, et al: Churg-Strauss syndrome and pulmonary fibrosis: an unusual association. Presse Med 2006;35(pt 1):1259–1262.
13.
Todd DC, Cockcroft DW: Prolonged survival in Churg-Strauss syndrome. Ann Allergy Asthma Immunol 2004;92:92–93.
14.
Matsuyama W, Mitsuyama H, Ono M, Shirahama Y, et al: Discoidin domain receptor 1 contributes to eosinophil survival in an NF-kappa B dependent manner in Churg-Strauss syndrome. Blood 2006; in press.
© 2007 S. Karger AG, Basel
2007
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.